These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8184551)

  • 1. Replication in cultured C2C12 muscle cells correlates with the neuroinvasiveness of California serogroup bunyaviruses.
    Griot C; Pekosz A; Davidson R; Stillmock K; Hoek M; Lukac D; Schmeidler D; Cobbinah I; Gonzalez-Scarano F; Nathanson N
    Virology; 1994 Jun; 201(2):399-403. PubMed ID: 8184551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of bunyavirus virulence. Comparative pathogenesis of a virulent strain of La Crosse and an avirulent strain of Tahyna virus.
    Janssen R; Gonzalez-Scarano F; Nathanson N
    Lab Invest; 1984 Apr; 50(4):447-55. PubMed ID: 6708454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry.
    Plassmeyer ML; Soldan SS; Stachelek KM; Martín-García J; González-Scarano F
    Virology; 2005 Jul; 338(1):121-32. PubMed ID: 15923017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of La Crosse virus is under polygenic control.
    Janssen RS; Nathanson N; Endres MJ; Gonzalez-Scarano F
    J Virol; 1986 Jul; 59(1):1-7. PubMed ID: 3712554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic control of neuroinvasiveness in California serogroup bunyaviruses.
    Griot C; Pekosz A; Lukac D; Scherer SS; Stillmock K; Schmeidler D; Endres MJ; Gonzalez-Scarano F; Nathanson N
    J Virol; 1993 Jul; 67(7):3861-7. PubMed ID: 8510208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropism of bunyaviruses: evidence for a G1 glycoprotein-mediated entry pathway common to the California serogroup.
    Pekosz A; Griot C; Nathanson N; Gonzalez-Scarano F
    Virology; 1995 Dec; 214(2):339-48. PubMed ID: 8553534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular determinants of the virulence and infectivity of California serogroup bunyaviruses.
    Griot C; Gonzalez-Scarano F; Nathanson N
    Annu Rev Microbiol; 1993; 47():117-38. PubMed ID: 8257095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The large viral RNA segment of California serogroup bunyaviruses encodes the large viral protein.
    Endres MJ; Jacoby DR; Janssen RS; Gonzalez-Scarano F; Nathanson N
    J Gen Virol; 1989 Jan; 70 ( Pt 1)():223-8. PubMed ID: 2732686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs.
    Blakqori G; Weber F
    J Virol; 2005 Aug; 79(16):10420-8. PubMed ID: 16051834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies.
    Pekosz A; Griot C; Stillmock K; Nathanson N; Gonzalez-Scarano F
    J Virol; 1995 Jun; 69(6):3475-81. PubMed ID: 7745694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroattenuation of an avirulent bunyavirus variant maps to the L RNA segment.
    Endres MJ; Griot C; Gonzalez-Scarano F; Nathanson N
    J Virol; 1991 Oct; 65(10):5465-70. PubMed ID: 1895395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steps of the tick-borne encephalitis virus replication cycle that affect neuropathogenesis.
    Mandl CW
    Virus Res; 2005 Aug; 111(2):161-74. PubMed ID: 15871909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function.
    Gonzalez-Scarano F; Janssen RS; Najjar JA; Pobjecky N; Nathanson N
    J Virol; 1985 Jun; 54(3):757-63. PubMed ID: 3889368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.
    Bennett RS; Cress CM; Ward JM; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2008 Feb; 5():25. PubMed ID: 18267012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine leukemia virus pseudotypes of La Crosse and Hantaan Bunyaviruses: a system for analysis of cell tropism.
    Ma M; Kersten DB; Kamrud KI; Wool-Lewis RJ; Schmaljohn C; González-Scarano F
    Virus Res; 1999 Oct; 64(1):23-32. PubMed ID: 10500280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. California serogroup gene structure-function relationships: virulence and tissue tropisms.
    Tignor GH; Burrage TG; Smith AL; Shope RE; Bishop DH
    Prog Clin Biol Res; 1983; 123():129-38. PubMed ID: 6867031
    [No Abstract]   [Full Text] [Related]  

  • 17. A new genetic variant of La Crosse virus (bunyaviridae) isolated from New England.
    Armstrong PM; Andreadis TG
    Am J Trop Med Hyg; 2006 Sep; 75(3):491-6. PubMed ID: 16968927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroattenuated bunyavirus variant: derivation, characterization, and revertant clones.
    Endres MJ; Valsamakis A; Gonzalez-Scarano F; Nathanson N
    J Virol; 1990 May; 64(5):1927-33. PubMed ID: 2182907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typing of LaCrosse, snowshoe hare, and Tahyna viruses by analyses of single-strand conformation polymorphisms of the small RNA segments.
    Black WC; Vanlandingham DL; Sweeney WP; Wasieloski LP; Calisher CH; Beaty BJ
    J Clin Microbiol; 1995 Dec; 33(12):3179-82. PubMed ID: 8586697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the La Crosse M segment proteins in a recombinant vaccinia expression system mediates pH-dependent cellular fusion.
    Jacoby DR; Cooke C; Prabakaran I; Boland J; Nathanson N; Gonzalez-Scarano F
    Virology; 1993 Apr; 193(2):993-6. PubMed ID: 8460503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.